Back to Search
Start Over
Ovarian cancer, version 3.2012.
- Source :
-
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2012 Nov 01; Vol. 10 (11), pp. 1339-49. - Publication Year :
- 2012
-
Abstract
- These NCCN Guidelines Insights focus on the major updates for the 2012 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Ovarian Cancer by describing how and why the new recommendations were made. The 6 update topics were selected based on recent important updates in the guidelines and on debate among panel members about recent clinical trials, and include: 1) screening, 2) diagnostic tests for assessing pelvic masses, 3) primary treatment using neoadjuvant chemotherapy, 4) primary adjuvant treatment using bevacizumab in combination with chemotherapy, 5) therapy for recurrent disease, and 6) management of drug/hypersensitivity reactions. These NCCN Guidelines Insights also discuss why some recommendations were not made (eg, panel members did not feel the new data warranted changing the guideline). See "Updates" in the NCCN Guidelines for Ovarian Cancer for a complete list of all the recent revisions.
- Subjects :
- Antineoplastic Combined Chemotherapy Protocols adverse effects
Chemotherapy, Adjuvant
Early Detection of Cancer
Female
Humans
Molecular Targeted Therapy
Neoadjuvant Therapy
Ovarian Neoplasms diagnosis
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Neoplasm Recurrence, Local therapy
Ovarian Neoplasms therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1540-1413
- Volume :
- 10
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Journal of the National Comprehensive Cancer Network : JNCCN
- Publication Type :
- Academic Journal
- Accession number :
- 23138163
- Full Text :
- https://doi.org/10.6004/jnccn.2012.0140